儿童体位性心动过速综合征诊治策略
收稿日期: 2022-04-02
网络出版日期: 2022-07-08
基金资助
北京大学临床医学+X 青年专项,中央高校基本科研业务费资助项目(No.PKU2022LCXQ028)
Diagnosis and treatment of postural tachycardia syndrome in children
Received date: 2022-04-02
Online published: 2022-07-08
体位性心动过速综合征(POTS)是一组以慢性直立不耐受及直立后心率过度增快为主要特征的临床综合征,在儿童及青少年时期较为常见,可显著影响儿童的生活质量及学习。POTS症状涉及多个系统,并可伴有多种共患疾病,临床表现复杂,在诊断中需详细询问病史,正确解读直立试验结果,谨慎鉴别诊断并全面评估共患病。POTS主要有相对低血容量、高肾上腺素能及血管功能障碍三种核心机制。在治疗POTS患儿时,应以非药物治疗为基础,针对患儿的临床特点及生物标志物水平评估主要发病机制,注意共患疾病的管理,从而进行个体化的综合治疗。
关键词: 体位性心动过速综合征; 直立不耐受; 直立试验; 共患病; 个体化治疗
廖莹 . 儿童体位性心动过速综合征诊治策略[J]. 临床儿科杂志, 2022 , 40(7) : 488 -493 . DOI: 10.12372/jcp.2022.22e0412
Postural orthostatic tachycardia syndrome (POTS) is a group of clinical syndromes characterized by chronic orthostatic intolerance and an excessive orthostatic heart rate increment. It is common both in children and adolescents and it can significantly affect children's learning and quality of life. POTS symptoms involve multiple systems and can be associated with multiple comorbidities. Since the clinical manifestations are complex, detailed history taking, correct interpretation of the results of standing test, careful differential diagnosis as well as comprehensive assessment of comorbidities are required when make a diagnosis of POTS for children. The pathogenesis of POTS mainly includes three core mechanisms: central hypovolemia, hyperadrenergic state and vascular dysfunction (partial autonomic neuropathy). In the treatment of POTS children, non-pharmacological therapy should be used as the basis. The main pathogenesis should be evaluated according to the clinical characteristics and certain biomarkers of the children, and attention should be paid to the management of comorbidities, so as to carry out individualized comprehensive treatment.
| [1] | Bryarly M, Phillips LT, Fu Q, et al. Postural orthostatic tachycardia syndrome: JACC focus seminar[J]. J Am Coll Cardiol, 2019, 73(10): 1207-1028. |
| [2] | Stewart JM, Gewitz MH, Weldon A, et al. Patterns of orthostatic intolerance: the orthostatic tachycardia syndrome and adolescent chronic fatigue[J]. J Pediatr, 1999, 135(2 Pt 1): 218-225. |
| [3] | Raj SR, Fedorowski A, Sheldon RS. Diagnosis and management of postural orthostatic tachycardia syndrome[J]. CMAJ, 2022, 194(10): E378-E385. |
| [4] | 张清友, 杜军保, 李万镇. 儿童体位性心动过速综合征的临床特征及随访研究[J]. 中华儿科杂志, 2005, 43(3): 165-169. |
| [5] | Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management[J]. J Intern Med, 2019, 285(4): 352-366. |
| [6] | Wang Y, Du J, Jin H, et al. Comorbidity of neurally mediated syncope and allergic disease in children[J]. Front Immunol, 2020, 11: 1865. |
| [7] | Wang Y, Du J, Li X, et al. Impact of comorbidities on the prognosis of pediatric postural tachycardia syndrome[J]. Int J Gen Med, 2021, 14: 8945-8954. |
| [8] | Zhao J, Han Z, Zhang X, et al. A cross-sectional study on upright heart rate and BP changing characteristics: basic data for establishing diagnosis of postural orthostatic tachycardia syndrome and orthostatic hypertension[J]. BMJ Open, 2015, 5(6): e007356. |
| [9] | Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope[J]. Heart Rhythm, 2015, 12(6): e41-e63. |
| [10] | Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS Guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society[J]. Circulation, 2017, 136(5): e60-e122. |
| [11] | Wang C, Li Y, Liao Y, et al. 2018 Chinese Pediatric Cardiology Society (CPCS) guideline for diagnosis and treatment of syncope in children and adolescents[J]. Sci Bull, 2018, 63: 1558-1564. |
| [12] | Moon J, Lee HS, Byun JI, et al. The complexity of diagnosing postural orthostatic tachycardia syndrome: influence of the diurnal variability[J]. J Am Soc Hypertens, 2016, 10(3): 263-270. |
| [13] | Liao Y, Du J. Pathophysiology and individualized management of vasovagal syncope and postural tachycardia syndrome in children and adolescents: an update[J]. Neurosci Bull, 2020, 36(6): 667-681. |
| [14] | Kharraziha I, Axelsson J, Ricci F, et al. Serum activity against G protein-coupled receptors and severity of orthostatic symptoms in postural orthostatic tachycardia syndrome[J]. J Am Heart Assoc, 2020, 9(15): e015989. |
| [15] | Gunning WT 3rd, Kvale H, Kramer PM, et al. Postural orthostatic tachycardia syndrome is associated with elevated G-protein coupled receptor autoantibodies[J]. J Am Heart Assoc, 2019, 8(18): e013602. |
| [16] | Monaco A, Choi D, Uzun S, et al. Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature[J]. Immunol Res, 2022: 1-13. |
| [17] | Chen G, Du J, Jin H, et al. Postural tachycardia syndrome in children and adolescents: pathophysiology and clinical management[J]. Front Pediatr, 2020, 8: 474. |
| [18] | Blitshteyn S. Vitamin B 1 deficiency in patients with postural tachycardia syndrome (POTS)[J]. Neurol Res, 2017, 39(8): 685-688 |
| [19] | Do T, Diamond S, Green C, et al. Nutritional implications of patients with dysautonomia and hypermobility syndromes[J]. Curr Nutr Rep, 2021, 10(4): 324-333. |
| [20] | Lin J, Zhao H, Shen J, et al. Salivary cortisol levels predict therapeutic response to a sleep-promoting method in children with postural tachycardia syndrome[J]. J Pediatr, 2017, 191: 91-95. |
| [21] | George SA, Bivens TB, Howden EJ, et al. The international POTS registry: Evaluating the efficacy of an exercise training intervention in a community setting[J]. Heart Rhythm, 2016, 13(4): 943-950. |
| [22] | Garland EM, Gamboa A, Nwazue VC, et al. Effect of high dietary sodium intake in patients with postural tachycardia syndrome[J]. J Am Coll Cardiol, 2021, 77(17): 2174-2184. |
| [23] | 廖莹, 杜军保. 儿童血管迷走性晕厥及体位性心动过速综合征治疗专家共识解读[J]. 中华儿科杂志, 2018, 56 (1): 10-12. |
| [24] | Zhang Q, Xu B, Du J. Update of Individualized treatment strategies for postural orthostatic tachycardia syndrome in children[J]. Front Neurol, 2020, 11: 525. |
| [25] | Li H, Wang Y, Liu P, et al. Body mass index (BMI) is associated with the therapeutic response to oral rehydration solution in children with postural tachycardia syndrome[J]. Pediatr Cardiol, 2016, 37(7): 1313-1318 |
| [26] | Lu W, Yan H, Wu S, et al. Hemocytometric measures predict the efficacy of oral rehydration for children with postural tachycardia syndrome[J]. J Pediatr, 2017, 187: 220-224. |
| [27] | Li H, Liao Y, Wang Y, et al. Baroreflex sensitivity predicts short-term outcome of postural tachycardia syndrome in children[J]. PLoS One, 2016, 11(12): e0167525. |
| [28] | Miller AJ, Raj SR. Pharmacotherapy for postural tachycardia syndrome[J]. Auton Neurosci, 2018, 215: 28-36. |
| [29] | Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1 [J]. Auton Neurosci, 2021, 235: 102828. |
| [30] | Lin J, Han Z, Li H, et al. Plasma C-type natriuretic peptide as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome[J]. PLoS One, 2015, 10(3): e0121913. |
| [31] | Wang YY, Han ZH, Wang YL, et al. Baseline left ventricular ejection fraction associated with symptom improvements in both children and adolescents with postural tachycardia syndrome under metoprolol therapy[J]. Chin Med J (Engl), 2021, 134(16): 1977-1982. |
| [32] | Wang Y, Zhang C, Chen S, et al. Heart rate variability predicts therapeutic response to metoprolol in children with postural tachycardia syndrome[J]. Front Neurosci, 2019, 13: 1214. |
| [33] | Mar PL, Raj SR. Postural orthostatic tachycardia syndrome: mechanisms and new therapies[J]. Annu Rev Med, 2020, 71: 235-248. |
| [34] | Wang S, Zou R, Cai H, et al. Predictive value of heart rate and blood pressure on the prognosis of postural tachycardia syndrome in children[J]. Front Pediatr, 2022, 10: 802469. |
| [35] | Yan H, Wang S, Cai H, et al. Prognostic value of biomarkers in children and adolescents with orthostatic intolerance[J]. Front Pediatr, 2021, 9: 752123. |
| [36] | Bai W, Chen SY, Jin HF, et al. Vascular dysfunction of postural tachycardia syndrome in children[J]. World J Pediatr, 2018, F14(1):13-17. |
| [37] | Bruce BK, Harrison TE, Bee SM, et al. Improvement in functioning and psychological distress in adolescents with postural orthostatic tachycardia syndrome following interdisciplinary treatment[J]. Clin Pediatr (Phila), 2016, 55(14): 1300-1304. |
| [38] | de Asmundis C, Chierchia GB, Sieira J, et al. Sinus node sparing novel hybrid approach for treatment of inappropriate sinus tachycardia/postural orthostatic sinus tachycardia with new electrophysiological finding[J]. Am J Cardiol 2019, 124(2): 224-232. |
/
| 〈 |
|
〉 |